What is HealthMpowerment?
HealthMpowerment (HMP) NextGen is a configurable digital health research platform that helps investigators launch mobile health studies faster, without the time and cost of building a custom solution from scratch.
Whether you’re conducting an implementation study, randomized controlled trial (RCT), SMART trial, pilot study, or longitudinal research project, HMP provides a proven foundation for participant engagement, intervention delivery, data collection, and study management. Designed to support diverse health topics, populations, and global settings, HMP helps research teams move more quickly from concept to impact.
Built by researchers. Continuously evolving.
HMP combines years of digital health research, behavioral science, and technology innovation into a platform that is constantly growing alongside the needs of the research community.
Beyond the technology itself, HMP offers access to evidence-informed health and wellness content that can be adapted, expanded, or used as a starting point for new interventions. Researchers may leverage existing content, create their own, or combine both approaches to meet the needs of their study population.
Our collaborative co-development model ensures that every enhancement strengthens the platform for future partners. New capabilities developed for one project become available to the next, reducing duplication of effort and allowing research teams to benefit from ongoing innovation.
Risk Reduction Findings
HMP has effectively reduced condomless anal intercourse (CAI) and HIV-related stigma among young Black gay and bisexual men living with or with increased likelihood for HIV. In an RCT comparing HMP to an information-only control arm, rates of CAI at 3-months were 32% lower in the HMP group (IR 0.68, 95% CI: 0.43, 0.93) and the intervention was more effective for participants who used HMP for more than 60 minutes during the 3-month intervention period. In subsequent mixed-methods analysis, online discussions around HIV stigma were associated with HIV-related communication (e.g., provider communication, HIV status disclosure to sexual partners) and improved HIV care outcomes (e.g., perceived barriers to treatment access, engagement in care, self-reported adherence) over time.
The U.S. Centers for Disease Control and Prevention (CDC) has identified HMP as a good evidence-based intervention (EBI) for HIV risk reduction. Good EBIs are scientifically sound and provide sufficient evidence of efficacy. Good EBIs offer promising evidence because they have demonstrated significant positive pre-post intervention differences in 1-group study designs. The CDC recommends health departments and community-based organizations implement evidence-based interventions. The dissemination of risk reduction EBIs is a critical part of building capacity among organizations that implement prevention programs for populations at risk for HIV. View the CDC’s description of HMP in their compendium here.
Projects
The HMP platform powers a range of research studies related to health and wellness worldwide. To learn more about each research project or about HMP's design framework, visit the HMP website:
